KWAG
ABBV icon

Kiely Wealth Advisory Group’s AbbVie ABBV Stock Holding History

Kiely Wealth Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$6.47K Hold
34
– – ﹤0.01% 233
2024
Q3 		$5.86K Hold
34
– – ﹤0.01% 239
2024
Q2 		$6.44K Buy
+34
New +$5.63K ﹤0.01% 215

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Kiely Wealth Advisory Group's ABBV Position: Q4 2024 in Review

Kiely Wealth Advisory Group held its AbbVie (ABBV) position steady in Q4 2024 at 34 shares worth $6.47K. The position accounts for ﹤0.01% of the portfolio, ranked #233.

Kiely Wealth Advisory Group first reported a position in ABBV in Q2 2024 and has held it in 3 quarters since. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Kiely Wealth Advisory Group held 34 shares of AbbVie worth $6.47K as of Q4 2024.
  • Kiely Wealth Advisory Group left its AbbVie share count unchanged in Q4 2024.
  • AbbVie made up ﹤0.01% of Kiely Wealth Advisory Group's portfolio in Q4 2024, its #233 holding.
  • Kiely Wealth Advisory Group first reported a position in AbbVie in Q2 2024 and has held it in 3 quarters since.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Kiely Wealth Advisory Group's 13F filing for Q4 2024, filed 12 Feb 2025.